BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1401189)

  • 1. Pseudohyperphosphataemia in patients with multiple myeloma.
    McClure D; Lai LC; Cornell C
    J Clin Pathol; 1992 Aug; 45(8):731-2. PubMed ID: 1401189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohyperphosphataemia in multiple myeloma.
    Hawkins RC
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():226-8. PubMed ID: 1872566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
    Sonnenblick M; Eylath U; Brisk R; Eldad C; Hershko C
    Clin Chem; 1986 Aug; 32(8):1537-9. PubMed ID: 3731447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method.
    Zaman Z; Sneyers L; Van Orshoven A; Blanckaert N; Mariën G
    Clin Chem; 1995 Apr; 41(4):609-14. PubMed ID: 7720254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraprotein interference causing pseudohyperphosphataemia: evaluation of an improved methodology.
    Savory DJ; Pearce CJ
    Ann Clin Biochem; 1995 Sep; 32 ( Pt 5)():498-501. PubMed ID: 8830626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin.
    Mandry JM; Posner MR; Tucci JR; Eil C
    Cancer; 1991 Sep; 68(5):1092-4. PubMed ID: 1913479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement.
    Bowles SA; Tait RC; Jefferson SG; Gilleece MH; Haeney MR
    Ann Clin Biochem; 1994 May; 31 ( Pt 3)():249-54. PubMed ID: 8067665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperphosphataemia in multiple myeloma.
    Lai LC; McClure D; Cornell C
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():237. PubMed ID: 1626934
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudohyperphosphataemia in multiple myeloma.
    Larner AJ
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():571-2. PubMed ID: 1308117
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of paraproteins by immunoturbidimetry and electrophoresis followed by scanning densitometry.
    Sinclair D; Ballantyne F; Shanley S; Caine E; O'Reilly D; Shenkin A
    Ann Clin Biochem; 1990 Jul; 27 ( Pt 4)():335-7. PubMed ID: 2119564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohyperphosphataemia in multiple myeloma.
    McCloskey EV; Galloway J; Morgan MA; Kanis JA
    BMJ; 1989 Dec; 299(6712):1381-2. PubMed ID: 2513970
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
    Gore ME; Riches PG; Kohn J
    J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraproteins: a regional South Australian experience.
    Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):187-95. PubMed ID: 12587843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand syndrome in multiple myeloma.
    Djunic I; Elezovic I; Ilic V; Tomin D; Suvajdzic-Vukovic N; Bila J; Antic D; Vidovic A; Milosevic-Jovcic N
    Hematology; 2011 Jul; 16(4):209-12. PubMed ID: 21756536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.